2006
DOI: 10.1161/01.atv.0000191634.13057.15
|View full text |Cite
|
Sign up to set email alerts
|

Circulating CD31 + /Annexin V + Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Artery Disease

Abstract: Objective-Endothelial dysfunction predicts morbidity and mortality in patients at cardiovascular risk. Endothelial function may be decisively influenced by the degree of endothelial cell apoptosis. Methods and Results-To test this hypothesis in humans, endothelial-dependent vasodilatation was invasively assessed in 50 patients with coronary artery disease (CAD) by quantitative coronary angiography during intracoronary acetylcholine infusion. Flow cytometry was used to assess endothelial cell apoptosis by quant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

11
224
3
3

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 298 publications
(241 citation statements)
references
References 33 publications
11
224
3
3
Order By: Relevance
“…An increase in EMP levels has been demonstrated in patients with cardiovascular disease, such as acute coronary syndromes, diabetes, hypertension and hypertriglyceridemia. [19][20][21][22][23] Microparticles can also influence endothelial functions: microparticles from patients with acute coronary syndromes directly impaired endothelium-dependent vasodilatation in rat aorta rings, presumably by inhibition of the nitric oxidemediated signal transduction. 9,10 Although microparticles are elevated in condition of endothelial 24 Endothelial cell dysfunction may be detected clinically by measuring impairment of endotheliumdependent vasodilation 25 or by determining the plasma levels of circulating soluble markers.…”
Section: Discussionmentioning
confidence: 99%
“…An increase in EMP levels has been demonstrated in patients with cardiovascular disease, such as acute coronary syndromes, diabetes, hypertension and hypertriglyceridemia. [19][20][21][22][23] Microparticles can also influence endothelial functions: microparticles from patients with acute coronary syndromes directly impaired endothelium-dependent vasodilatation in rat aorta rings, presumably by inhibition of the nitric oxidemediated signal transduction. 9,10 Although microparticles are elevated in condition of endothelial 24 Endothelial cell dysfunction may be detected clinically by measuring impairment of endotheliumdependent vasodilation 25 or by determining the plasma levels of circulating soluble markers.…”
Section: Discussionmentioning
confidence: 99%
“…An increase in endothelial microparticle (EMP) levels has been demonstrated in patients with cardiovascular disease, such as acute coronary syndromes, diabetes, hypertension and hypertriglyceridemia. [29][30][31][32][33] Microparticles can also influence endothelial functions: microparticles from patients with acute coronary syndromes directly impaired endothelium-dependent vasodilatation in rat aorta-rings, presumably by inhibition of the nitric oxide-mediated signal transduction. 34,35 Although microparticles are elevated in condition of endothelial cell loss, as a consequence of inflammatory processes and the associated vascular damage, they may play a direct role in atherogenesis, also considering that EMPs can directly activate and stimulate cells to produce inflammatory mediators such as cytokines.…”
Section: Endothelial Microparticles and Edmentioning
confidence: 99%
“…EMPs are very heterogeneous; the phenotype and functional properties vary according to factors involved in their release (22,25). Moreover, an elevated number of EMPs reflects cellular injury as a surrogate marker of vascular dysfunction in cardiovascular disease (40). In our study, CKD patients with VC had a greater number of EMPs than patients without VC.…”
Section: Discussionmentioning
confidence: 52%